These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

23 related articles for article (PubMed ID: 28843379)

  • 1. A response to Germain, et al. The effect of enzyme replacement therapy on clinical outcomes in male patients with Fabry disease: A systematic literature review by a European panel of experts.
    Gurevich A; Schenk J; Wellhoefer H; Kalampoki V
    Mol Genet Metab Rep; 2019 Jun; 19():100471. PubMed ID: 31011537
    [No Abstract]   [Full Text] [Related]  

  • 2. Corrigendum to "Lack of Gα
    Leiss V; Schönsiegel A; Gnad T; Kerner J; Kaur J; Sartorius T; Machann J; Schick F; Birnbaumer L; Häring HU; Pfeifer A; Nürnberg B
    Mol Metab; 2024 Apr; 82():101910. PubMed ID: 38442877
    [No Abstract]   [Full Text] [Related]  

  • 3. Corrigendum to "Elevation of hypothalamic ketone bodies induces a decrease in energy expenditures and an increase risk of metabolic disorder" [Mol Metab, 83 (2024) 101926].
    Carneiro L; Bernasconi R; Bernini A; Repond C; Pellerin L
    Mol Metab; 2024 May; 83():101937. PubMed ID: 38621668
    [No Abstract]   [Full Text] [Related]  

  • 4. Corrigendum to "Beta cell specific cannabinoid 1 receptor deletion counteracts progression to hyperglycemia in non-obese diabetic mice" [Mol Metab 82 (2024 April) 101906].
    Aseer KR; Mazucanti CH; O'Connell JF; González-Mariscal I; Verma A; Yao Q; Dunn C; Liu QR; Egan JM; Doyle ME
    Mol Metab; 2024 Apr; 82():101917. PubMed ID: 38499184
    [No Abstract]   [Full Text] [Related]  

  • 5. Corrigendum to "Inter-domain tagging implicates caveolin-1 in insulin receptor trafficking and Erk signaling bias in pancreatic beta-cells" [Mol Metab 2016 May; 5 (5): 366-378].
    Boothe T; Lim GE; Cen H; Skovsø S; Piske M; Li SN; Nabi IR; Gilon P; Johnson JD
    Mol Metab; 2024 May; 83():101935. PubMed ID: 38604236
    [No Abstract]   [Full Text] [Related]  

  • 6. Chronic pain in Gaucher disease: skeletal or neuropathic origin?
    Devigili G; De Filippo M; Ciana G; Dardis A; Lettieri C; Rinaldo S; Macor D; Moro A; Eleopra R; Bembi B
    Orphanet J Rare Dis; 2017 Aug; 12(1):148. PubMed ID: 28859662
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Skeletal aspects of Gaucher disease: a review.
    Wenstrup RJ; Roca-Espiau M; Weinreb NJ; Bembi B
    Br J Radiol; 2002; 75 Suppl 1():A2-12. PubMed ID: 12036828
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Corrigendum to "Retinal thinning in Gaucher disease patients and carriers: Results of a pilot study" [Mol. Genet. Metab. 109 (2013) 221-223].
    McNeill A; Roberti G; Lascaratos G; Hughes D; Mehta A; Garway-Heath DF; Schapira AHV
    Mol Genet Metab; 2014 Mar; 111(3):408. PubMed ID: 28843379
    [No Abstract]   [Full Text] [Related]  

  • 9. Corrigendum to "Risk factors for developing mineral bone disease in phenylketonuric patients" [Mol. Genet. Metab. 108 (2013) 149-154].
    Mirás A; Dolores Bóveda M; Leis MR; Mera A; Aldámiz-Echevarría L; Fernández-Lorenzo JR; Fraga JM; Couce ML
    Mol Genet Metab; 2015 Mar; 114(3):483. PubMed ID: 25877473
    [No Abstract]   [Full Text] [Related]  

  • 10. Corrigendum to "Clinical and metabolic findings in patients with methionine adenosyltransferase I/III deficiency detected by newborn screening" [Mol. Genet. Metab. 110 (2013) 218-221].
    Couce ML; Dolores Bóveda M; García-Jimémez C; Balmaseda E; Vives I; Castiñeiras DE; Fernández-Marmiesse A; Fraga JM; Mudd SH; Corrales FJ
    Mol Genet Metab; 2015 Mar; 114(3):486. PubMed ID: 25877476
    [No Abstract]   [Full Text] [Related]  

  • 11. Corrigendum to "GJC2 promoter mutations causing Pelizaeus-Merzbacher-like disease" [Mol. Genet. Metab. 111 (2014) 393-398].
    Gotoh L; Inoue K; Helman G; Mora S; Maski K; Soul JS; Bloom M; Evans SH; Goto YI; Caldovic L; Hobson GM; Vanderver A
    Mol Genet Metab; 2016 Nov; 119(3):293. PubMed ID: 27780564
    [No Abstract]   [Full Text] [Related]  

  • 12. Corrigendum to "A glimpse into past, present, and future DNA sequencing" [Mol. Genet. Metab. 110 (2013) 3-24].
    Morey M; Fernández-Marmiesse A; Castiñeiras D; Fraga JM; Couce ML; Cocho JA
    Mol Genet Metab; 2015 Mar; 114(3):484. PubMed ID: 25877474
    [No Abstract]   [Full Text] [Related]  

  • 13. Corrigendum to "Next generation sequencing of patients with mut methylmalonic aciduria: Validation of somatic cell studies and identification of 16 novel mutations." [Mol. Genet. Metab. (Aug 2016); 118(4): 264-71].
    Chu J; Pupavac M; Watkins D; Tian X; Feng Y; Chen S; Fenter R; Zhang VW; Wang J; Wong LJ; Rosenblatt DS
    Mol Genet Metab; 2017 Mar; 120(3):295. PubMed ID: 28284539
    [No Abstract]   [Full Text] [Related]  

  • 14.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 2.